Jonathan Jay Mazelsky, President & CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 11,940 shares at $675.34 ($8.1M) on 2021-08-13, disclosed to the SEC on 2021-08-17.
Open-market sale of $8.1M IDXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $675.34 | 3,417 | $2.3M | 28.6% |
| 2 | $675.34 | 3,417 | $2.3M | 28.6% |
| 3 | $676.38 | 983 | $665K | 8.2% |
| 4 | $676.38 | 983 | $665K | 8.2% |
| 5 | $677.58 | 337 | $228K | 2.8% |
| 6 | $677.58 | 337 |
| $228K |
| 2.8% |
| 7 | $672.36 | 533 | $358K | 4.4% |
| 8 | $672.36 | 533 | $358K | 4.4% |
| 9 | $673.69 | 488 | $329K | 4.1% |
| 10 | $673.69 | 488 | $329K | 4.1% |
| 11 | $674.48 | 182 | $123K | 1.5% |
| 12 | $674.48 | 182 | $123K | 1.5% |
| 13 | $675.44 | 60 | $41K | 0.5% |
| Total | $675.21 avg | 11,940 | $8.1M | 100% |
| Filing → |
| IDXX | SELL | 2024-02-09 | $13.7M | — | Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |